In Global News: Early Menopause From Chemotherapy, Cardiovascular Disease Risk App, and New ESC/EACTS Guidelines [1]
Patient Care and General Interest
Late-breaking results from the VISION study just presented at the European Society of Cardiology’s 2018 annual Congress suggest that 75% of patient deaths after noncardiac surgery can be attributed to cardiovascular causes [3].
Access to the Affordable Care Act in the United States has seemingly made middle-aged stroke survivors less likely to skip prescribed medications due to cost. [4]
A new study suggests that chemotherapy may lead to early menopause [5] in young women with lung cancer.
Drugs and Devices
A new Astrazeneca drug called Tagrisso has been approved in Japan for patients [6] with inoperable or recurrent epidermal growth factor receptor mutation-positive non-small-cell lung cancer.
The Duke Clinical Research Institute and Cerner have jointly developed an app that estimates patients’ cardiovascular disease risk [7].
Research, Trials, and Funding
A new study published in the Journal of the American Heart Association finds that a simplified cardiac magnetic resonance protocol can help developing nations [8] diagnose heart ailments more quickly and cheaply.
A meta-analysis published in JAMA Cardiology finds that young and middle-aged adults with aortic valve disease [9] have a higher survival rate when treated via the Ross procedure as opposed to mechanical aortic valve replacement.
New guidelines on clinical care for patients undergoing myocardial revascularization [10] have been released by the European Society of Cardiology and European Association for Cardio-Thoracic Surgery.